Peroxisome proliferation and hepatocarcinogenesis
Reddy, J.K.; Rao, M.S.
Iarc Scientific Publications 116: 225-235
1992
ISSN/ISBN: 0300-5038 PMID: 1428083 Document Number: 404878
Document emailed within 1 workday
Related Documents
Marsman, D.S.; Cattley, R.C.; Conway, J.G.; Popp, J.A. 1988: Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats Cancer Research 48(23): 6739-6744Takagi, A.; Sai, K.; Umemura, T.; Hasegawa, R.; Kurokawa, Y. 1992: Hepatomegaly is an early biomarker for hepatocarcinogenesis induced by peroxisome proliferators Journal of Environmental Pathology Toxicology and Oncology: Official Organ of the International Society for Environmental Toxicology and Cancer 11(3): 145-149
Zambrano, M.; Fernández, E.; López, M.; Rangel, A.; de Romero, P.; Fernández, V.; Marina Morales, L.; Molero-Conejo, E.; Connell, L.; Raleigh, X.; Aranguren-Mendez, J.é 2009: Gly482Ser polymorphism of the coactivator-1alpha of the activated receptor of peroxisome gamma proliferation in individuals from Maracaibo, Venezuela Investigacion Clinica 50(3): 285-294
Mustafin, A.G. 1976: Circadian rhythms of cell proliferation in mice during the early stages of hepatocarcinogenesis induced by ortho-aminoazotoluol Biulleten' Eksperimental'noi Biologii i Meditsiny 82(7): 856-858
Stevens, T.J.; Stafford, W.W.; Day, C.E.; Block, E.M. 1983: Comparison of clofibrate and ethyl-5-(p-chlorophenoxy)-3-hydroxy-3-methylpentanoate induced changes in serum lipoprotein cholesterol and hepatic peroxisome proliferation in the normal rat Artery 12(2): 81-94
Sakai, M.; Matsushima-Hibiya, Y.; Nishizawa, M.; Nishi, S. 1995: Suppression of rat glutathione transferase P expression by peroxisome proliferators: interaction between Jun and peroxisome proliferator-activated receptor alpha Cancer Research 55(22): 5370-5376
Zhang, C-hua.; Wen, Z-qing.; Li, J-feng.; Li, C-zhong.; Shi, M.; Yang, G-wen.; Lan, S-min.; Zhu, Y.; Wang, F.; Zhang, Y-jing.; Wang, Y-ying.; Zhang, H. 2008: Inhibition of proliferation and transforming growth factor beta3 protein expression by peroxisome proliferators-activated receptor gamma ligands in human uterine leiomyoma cells Chinese Medical Journal 121(2): 166-171
Herens, C.; Jacquemart, M.; Koulischer, L.; Barbason, H. 1995: Nuclear lesions during rat hepatocarcinogenesis. I. Measuring the sister-chromatid exchanges during initiation, promotion and progression of rat hepatocarcinogenesis induced with diethylnitrosamine Mutation Research 329(2): 153-159
Lalwani, N.D.; Reddy, M.K.; Qureshi, S.A.; Moehle, C.M.; Hayashi, H.; Reddy, J.K. 1983: Noninhibitory effect of antioxidants ethoxyquin, 2(3)-tert-butyl-4-hydroxyanisole and 3,5-di-tert-butyl-4-hydroxytoluene on hepatic peroxisome proliferation and peroxisomal fatty acid beta-oxidation induced by a hypolipidemic agent in rats Cancer Research 43(4): 1680-1687
Maver, A.; Medica, I.; Salobir, B.; Tercelj-Zorman, M.; Sabovic, M.; Petrovic, D.; Peterlin, B. 2008: Peroxisome proliferator-activated receptor gamma/Pro12Ala polymorphism and peroxisome proliferator-activated receptor gamma coactivator-1 alpha/Gly482Ser polymorphism in patients with sarcoidosis Sarcoidosis Vasculitis and Diffuse Lung Diseases: Official Journal of Wasog 25(1): 29-35
Moser, H.W. 1999: The peroxisome: structure, function and biogenesis Revista de Neurologia 28(Suppl 1): S37-S39
Ghizzi, A.; Gorini, M.; Ascari, E. 1985: "in vitro" growth acceleration of CFU-GM proliferation: a new criterion of measure of proliferation features of granulocytic progenitor cells Haematologica 70(6): 482-486
Russell, J.H.; Manning, D.E.; McCulley, D.E.; Meleedy-Rey, P. 1988: Antigen as a positive and negative regulator of proliferation in cytotoxic lymphocytes. A model for the differential regulation of proliferation and lytic activity Journal of Immunology 140(6): 1796-1801
Becker, F.F. 1983: Thioacetamide hepatocarcinogenesis Journal of the National Cancer Institute 71(3): 553-558
Canuto, R.A.; Muzio, G.; Bonelli, G.; Maggiora, M.; Autelli, R.; Barbiero, G.; Costelli, P.; Brossa, O.; Baccino, F.M. 1998: Peroxisome proliferators induce apoptosis in hepatoma cells Cancer Detection and Prevention 22(4): 357-366
Norata, G.D.; Pellegatta, F.; Catapano, A.L. 2003: Peroxisome proliferator activated receptors and cardiovascular disorders Italian Heart Journal. Suppl: Official Journal of the Italian Federation of Cardiology 4(1): 8-18
Koike, K. 1999: Co-infection of HBV with HCV and a possible role of HBV DNA in hepatocarcinogenesis Nihon Rinsho. Japanese Journal of Clinical Medicine 57(1): 213-219
Ozturk, M.; Ponchel, F.; Puisieux, A.; Marçais, C. 1993: The p53 gene in human hepatocarcinogenesis Pathologie-Biologie 41(1): 21
Sandgren, E.P.; Merlino, G. 1995: Hepatocarcinogenesis in transgenic mice Progress in Clinical and Biological Research 391: 213-222
Knapp, P.ł; Jarzabek, K.; Błachnio, A.; Zbroch, T. 2006: The role of peroxisome proliferator-activated receptors (PPAR) in carcinogenesis Ginekologia Polska 77(8): 643-651